Sofía Bruni

635 total citations
13 papers, 383 citations indexed

About

Sofía Bruni is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sofía Bruni has authored 13 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Immunology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sofía Bruni's work include Monoclonal and Polyclonal Antibodies Research (7 papers), Immunotherapy and Immune Responses (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Sofía Bruni is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), Immunotherapy and Immune Responses (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Sofía Bruni collaborates with scholars based in Argentina, United States and South Korea. Sofía Bruni's co-authors include Roxana Schillaci, María F. Mercogliano, Patricia V. Elizalde, Rosalía I. Cordo Russo, Benjamin D. Greenbaum, Theresa A. Proia, Dana Pe’er, James P. Allison, Matthew E. Griffin and Elaine R. Mardis and has published in prestigious journals such as Cancer Research, Annals of the New York Academy of Sciences and Cell Death and Disease.

In The Last Decade

Sofía Bruni

12 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sofía Bruni Argentina 7 193 131 130 56 41 13 383
Lihua Sun China 9 134 0.7× 128 1.0× 119 0.9× 58 1.0× 80 2.0× 11 373
Ritu Arora United States 8 150 0.8× 109 0.8× 152 1.2× 90 1.6× 26 0.6× 15 351
Pingqing He China 8 133 0.7× 106 0.8× 157 1.2× 65 1.2× 28 0.7× 8 367
Xiangbo Meng China 7 147 0.8× 123 0.9× 184 1.4× 50 0.9× 32 0.8× 12 358
You-Soo Park South Korea 16 324 1.7× 396 3.0× 181 1.4× 44 0.8× 49 1.2× 27 611
Iryna Kolosenko Sweden 11 116 0.6× 68 0.5× 237 1.8× 91 1.6× 25 0.6× 19 383
Cheol‐Hun Son South Korea 12 212 1.1× 259 2.0× 97 0.7× 23 0.4× 36 0.9× 16 402
Zhuangzhuang Liang China 10 221 1.1× 108 0.8× 152 1.2× 79 1.4× 53 1.3× 23 465
Thomas D. Hart United States 10 180 0.9× 105 0.8× 171 1.3× 41 0.7× 43 1.0× 13 361
Xiangqi Li China 11 116 0.6× 51 0.4× 217 1.7× 62 1.1× 49 1.2× 33 405

Countries citing papers authored by Sofía Bruni

Since Specialization
Citations

This map shows the geographic impact of Sofía Bruni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofía Bruni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofía Bruni more than expected).

Fields of papers citing papers by Sofía Bruni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofía Bruni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofía Bruni. The network helps show where Sofía Bruni may publish in the future.

Co-authorship network of co-authors of Sofía Bruni

This figure shows the co-authorship network connecting the top 25 collaborators of Sofía Bruni. A scholar is included among the top collaborators of Sofía Bruni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofía Bruni. Sofía Bruni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Bruni, Sofía, Ernesto Gil Deza, Elmer A. Fernández, et al.. (2025). Mucin 4 expression is associated with metastasis in triple-negative breast cancer and can be tackled by soluble TNF blockade, improving immunotherapy outcome. Translational Oncology. 54. 102325–102325. 1 indexed citations
2.
Bruni, Sofía, et al.. (2023). Cancer immune exclusion: breaking the barricade for a successful immunotherapy. Frontiers in Oncology. 13. 1135456–1135456. 23 indexed citations
3.
Mercogliano, María F., et al.. (2023). Emerging Targeted Therapies for HER2-Positive Breast Cancer. Cancers. 15(7). 1987–1987. 83 indexed citations
4.
Izzo, Franco, Violeta A. Chiauzzi, Sofía Bruni, et al.. (2022). Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer. Cell Death and Disease. 13(5). 447–447. 9 indexed citations
5.
Schillaci, Roxana, Sofía Bruni, María F. Mercogliano, et al.. (2022). Abstract P5-13-32: Mucin 4 expression in high risk breast cancer: Predicting and overcoming resistance to immunotherapy. Cancer Research. 82(4_Supplement). P5–13. 3 indexed citations
6.
Bruni, Sofía, María F. Mercogliano, Cecilia J. Proietti, et al.. (2022). Abstract 2047: MUC4 enables immune tumor evasion in HER2+ breast cancer. Cancer Research. 82(12_Supplement). 2047–2047. 1 indexed citations
7.
Bruni, Sofía, Mara De Martino, Cecilia J. Proietti, et al.. (2022). 877 Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression. Regular and Young Investigator Award Abstracts. A914–A914.
8.
Mercogliano, María F., et al.. (2021). Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy. Cancers. 13(3). 564–564. 76 indexed citations
9.
Mercogliano, María F., Sofía Bruni, Patricia V. Elizalde, & Roxana Schillaci. (2020). Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer. Frontiers in Oncology. 10. 584–584. 121 indexed citations
10.
Martino, Mara De, Mercedes Tkach, Sofía Bruni, et al.. (2020). Blockade of Stat3 oncogene addiction induces cellular senescence and reveals a cell-nonautonomous activity suitable for cancer immunotherapy. OncoImmunology. 9(1). 1715767–1715767. 18 indexed citations
11.
Cable, Jennifer, Benjamin D. Greenbaum, Dana Pe’er, et al.. (2020). Frontiers in cancer immunotherapy—a symposium report. Annals of the New York Academy of Sciences. 1489(1). 30–47. 43 indexed citations
12.
13.
Mercogliano, María F., Mara De Martino, Sofía Bruni, et al.. (2017). Abstract 1195: TNFα induces multiresistance to HER2-targeted TNFα induces multiresistance to HER2-targeted therapies in HER2-positive breast cancer. Cancer Research. 77(13_Supplement). 1195–1195. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lihua Sun Breakdown of academic impact, for papers by Ritu Arora Breakdown of academic impact, for papers by Pingqing He Breakdown of academic impact, for papers by Xiangbo Meng Breakdown of academic impact, for papers by You-Soo Park Breakdown of academic impact, for papers by Iryna Kolosenko Breakdown of academic impact, for papers by Cheol‐Hun Son Breakdown of academic impact, for papers by Zhuangzhuang Liang Breakdown of academic impact, for papers by Thomas D. Hart Breakdown of academic impact, for papers by Xiangqi Li
Rankless by CCL
2026